By 2030, 1.1 billion women worldwide will be in menopause. According to Mayo Clinic research, menopause-related productivity loss already exceeds $150 billion. The Pause empowers women to navigate perimenopause and menopause through trusted, AI-driven mobile solutions designed to improve daily function, enhance health outcomes, and restore quality of life. Our approach builds trust through real-time support, grounded in science and centered on each woman’s unique experience.

By 2030, 1.1 billion women worldwide will be in menopause. According to Mayo Clinic research, menopause-related productivity loss already exceeds $150 billion. The Pause empowers women to navigate perimenopause and menopause through trusted, AI-driven mobile solutions designed to improve daily function, enhance health outcomes, and restore quality of life. Our approach builds trust through real-time support, grounded in science and centered on each woman’s unique experience.

Through our participation in the Mayo Clinic MedTech Accelerator, we refined our vision to position The Pause as the most trusted AI platform for perimenopause and menopause care. Access to world-class leaders in medicine, business, and technology has provided critical insight on how to scale responsibly—balancing innovation with clinical rigor. As a result, we are strengthening our roadmap, validating outcomes, and accelerating pathways to strategic partnerships.

"The MedTech Accelerator has been transformative - sharpening our strategy, expanding our network, and aligning The Pause with the highest standards of clinical excellence and innovation."

Susan Sly
Founder and CEO, the Pause